Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of 24-hour trough FEV1 after 7 days of CHF4226 once daily in asthma
2005-002195-15Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing CHF4226 once daily with Placebo (2 arms). Primary endpoint: Trough FEV1 at Day 8. Started Jun 2005; status: completed.
02
Drugs
carmoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-002195-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002195-15.